Government confirms bivalent vaccine supply Moderna will deliver 15 million doses of its new Omicron-specific vaccine by the end of the year, with doses set to become available next month.
Vaccine rollout ‘relied on GP goodwill’: Study General practices involved in Australia’s COVID-19 vaccination program struggled to make ends meet, researchers say.
TGA approves Omicron-specific vaccine The ‘bivalent’ COVID-19 vaccine, developed by Moderna, has been given the go-ahead by the Australian medicines regulator.
ATAGI releases Novavax guidance for adolescents The new advice means adolescents aged 12–17 years will have another COVID-19 vaccine option from 5 September.
BCG vaccine also boosts non-TB immune system: Study But while BCG is the world’s most commonly used vaccine, it has not been routinely administered in Australia since 1985.
Vaccine rollout lessons put on hold An Audit Office report contains criticisms of planning and communication but offers few concrete suggestions for improvement.
First country approves Moderna vaccine targeting Omicron The approval comes in the same week that Monash University was selected to house the first mRNA production facility in the Southern Hemisphere.
ATAGI approves Moderna vaccine for at-risk young children Parents are advised not to contact vaccine providers until bookings open, following decision to approve vaccination for the youngest cohort.
Monkeypox now a disease of ‘national significance’ The declaration was made by Australia’s CMO, while ATAGI has also released updated guidance on vaccination.
Short EOI window for paediatric COVID shots Expressions of interest for the six-month to four-year-old cohort are now being accepted, but general practices only have until Friday to nominate.